secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMPEL PHARMACEUTICALS INC (—)
CIK:        0001445499
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001193125-24-065453
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Impel Pharmaceuticals changes name to IPI Legacy Liquidation Co effective March 8, 2024
--------------------------------------------------------------------------------

- Name changed from Impel Pharmaceuticals Inc. to IPI Legacy Liquidation Co via certificate of amendment.
- Name change did not require stockholder approval under Delaware General Corporation Law.
- Common stock trades on OTC Pink under symbol IMPLQ following Nasdaq delisting.
- Certificate of Amendment filed as Exhibit 3.1 to the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445499/000119312524065453/0001193125-24-065453-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445499/000119312524065453/d803206d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-065453

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer